Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing drug-eluting stents versus drug-coated balloons to prevent recurrent in-stent restenosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drug-eluting stents
  • drug-coated balloon

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Restenosis | Phase 4 | Status: TERMINATED